Testing lacosamide for hard-to-treat bipolar depression
Treatments studied
Part of Mental health clinical trials.
This study tests if a medication called lacosamide can help people with bipolar depression that has not improved with at least two other treatments. It's for those with moderate to severe depression in bipolar I or II.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have bipolar disorder (type I or II) diagnosed by a doctor.
- You are currently in a moderate or severe depressive episode.
- You have tried at least two different treatments for this depression and they didn't work.
- You do not have active suicidal thoughts or plans.
- You are not pregnant or have unstable medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This trial tests a closed-loop deep brain stimulation system for people with bipolar II disorder whose depression has not responded to standard treatments. The device sends targeted electrical pulses to the brain based on real-time activity, aiming to reduce depression symptoms.
This Phase 2 study tests a medication that works on NMDA receptors to improve depression symptoms in people with bipolar I disorder. It may help if you’re currently in a bipolar depression episode and other mood treatments haven’t fully controlled it.
This study tests a new medication called lumateperone for treating depression in children and teens with bipolar disorder. It aims to see if this drug can help improve mood and daily functioning.
This study compares two medications, Lumateperone and Cariprazine, to see which works better and has fewer side effects for people with bipolar I depression. It may help find a more effective treatment for your depressive symptoms.
This trial tests whether OSU6162 can improve depressive symptoms in adults with bipolar depression who are already taking a stable mood-stabilizing medicine. It also checks safety by closely monitoring mood, heart rhythm, and other health factors during the study.
Hear when a new Bipolar Affective Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.